BMO Alternative Strategies Fund OCSE:NOVO B Holdings History
BMO Alternative Strategies Fund's Novo Nordisk AS Holding Summary
As of 2020-05-31, BMO FUNDS, INC. held 3,998.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr130,330.00. This investment constitutes 2.88% of their stock portfolio, and BMO FUNDS, INC. now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q4. And since then BMO Alternative Strategies Fund has made 1 purchases of OCSE:NOVO B, at an average price of kr184.23, for a total of 7,430.00 shares. In addition, there have been 1 sales at an average price of kr207.59 for 3,432.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr442.80, BMO Alternative Strategies Fund's estimated gain on his OCSE:NOVO B holdings is kr1.11 Mil, reflecting a 81.38% gain to date.
BMO Alternative Strategies Fund OCSE:NOVO B (kr442.80) Holding Chart
BMO Alternative Strategies Fund OCSE:NOVO B (kr442.80) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
